Clinical Trial Update: Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update on prevention of bone loss after pediatric hematopoietic cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Osteopenia, Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2024-02-20